Literature DB >> 33669375

PET/CT Imaging for Personalized Management of Infectious Diseases.

Jordy P Pijl1, Thomas C Kwee1, Riemer H J A Slart1,2, Andor W J M Glaudemans1.   

Abstract

Positron emission tomography combined with computed tomography (PET/CT) is a nuclear imaging technique which is increasingly being used in infectious diseases. Because infection foci often consume more glucose than surrounding tissue, most infections can be diagnosed with PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose (FDG), an analogue of glucose labeled with Fluorine-18. In this review, we discuss common infectious diseases in which FDG-PET/CT is currently applied including bloodstream infection of unknown origin, infective endocarditis, vascular graft infection, spondylodiscitis, and cyst infections. Next, we highlight the latest developments within the field of PET/CT, including total body PET/CT, use of novel PET radiotracers, and potential future applications of PET/CT that will likely lead to increased capabilities for patient-tailored treatment of infectious diseases.

Entities:  

Keywords:  FDG-PET/CT; bloodstream infection; cyst infection; endocarditis; infection; radiotracers; spondylodiscitis; total body PET/CT; vascular graft infection; white blood cell scintigraphy

Year:  2021        PMID: 33669375     DOI: 10.3390/jpm11020133

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  2 in total

Review 1.  Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.

Authors:  George Crișan; Nastasia Sanda Moldovean-Cioroianu; Diana-Gabriela Timaru; Gabriel Andrieș; Călin Căinap; Vasile Chiș
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 2.  Long axial field of view PET scanners: a road map to implementation and new possibilities.

Authors:  Riemer H J A Slart; Charalampos Tsoumpas; Andor W J M Glaudemans; Walter Noordzij; Antoon T M Willemsen; Ronald J H Borra; Rudi A J O Dierckx; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-16       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.